{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Juniperus procera (Arar)", "anticancer activities", "enzyme inhibition", "in silico", "ovarian cancer", "protein docking"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38681095", "DateRevised": {"Year": "2024", "Month": "04", "Day": "30"}, "Article": {"Language": ["eng"], "ELocationID": ["11779322241248904", "10.1177/11779322241248904"], "ArticleDate": [{"Year": "2024", "Month": "04", "Day": "25"}], "Journal": {"ISSN": "1177-9322", "JournalIssue": {"Volume": "18", "PubDate": {"Year": "2024"}}, "Title": "Bioinformatics and biology insights", "ISOAbbreviation": "Bioinform Biol Insights"}, "ArticleTitle": "The Potential Role of Phytochemicals of <i>Juniperus procera</i> in the Treatment of Ovarian Cancer and the Inhibition of Human Topoisomerase II Alpha Activity.", "Pagination": {"StartPage": "11779322241248904", "MedlinePgn": "11779322241248904"}, "Abstract": {"AbstractText": ["A variety of active chemicals found in medicinal plants can be used to develop new medications with few adverse effects. In vitro and in silico analyses were used to evaluate the anticancer properties of <i>Juniperus procera</i> fruit and leaf extracts. Here, we show that the methanolic extract from <i>J procera</i> fruit and leaf extracts inhibits 2 human ovarian cancer cell lines, A2780CP and SKOV-3. The leaf extract demonstrated strong cytotoxicity against A2780CP with an IC50 of 1.2\u2009\u03bcg/mL, almost matching the IC50 of the anticancer medication doxorubicin (0.9\u2009\u03bcg/mL). Higher antioxidant activity was observed in the fruit than leaf extract. The molecular docking results showed that the active component, podocarpusflavone A, was the best-docked chemical with the human topoisomerase II alpha enzyme. According to our knowledge, this is the first in vitro study to show the cytotoxicity of <i>J procera</i> extracts against the 2 previously described human ovarian cancer cell lines. The fact that the podocarpusflavone A molecule may have an inhibitory effect on the human topoisomerase II alpha enzyme was also revealed by this first in silico analysis. Our findings imply that the <i>J procera</i> fruit and leaf methanolic extract has anticancer characteristics that may guide future in vivo studies."], "CopyrightInformation": "\u00a9 The Author(s) 2024."}, "AuthorList": [{"Identifier": ["0000-0002-3359-7187"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, University College at Al-Qunfudhah, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Al-Zahrani", "ForeName": "Ateeq A", "Initials": "AA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioinform Biol Insights", "NlmUniqueID": "101467187", "ISSNLinking": "1177-9322"}, "CoiStatement": "The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;100:72-79.", "ArticleIdList": ["16009521"]}, {"Citation": "Latif A, Amer HM, Hamad ME, Alarifi SAR, Almajhdi FN. Medicinal plants from Saudi Arabia and Indonesia: in vitro cytotoxicity evaluation on Vero and Hep-2 cells. J Med Plants Res. 2014;8:1065-1073."}, {"Citation": "Al-Zahrani AA. Rutin as a promising inhibitor of main protease and other protein targets of Covid-19: in silico study. Nat Prod Commun. 2020;15:1934578X20953951."}, {"Citation": "Abdelghany TM, Hassan MM, El-Naggar MA. GC/MS analysis of Juniperus procera extract and its activity with silver nanoparticles against Aspergillus flavus growth and aflatoxins production. Biotechnol Rep (Amsterdam). 2020;27:e00496.", "ArticleIdList": ["PMC7327896", "32637346"]}, {"Citation": "Magdah G. Cytogenetic toxicity of Juniperus procera extract with silver nanoparticles against carcinoma colon (Caco2) cell line in vitro. Int J Pharmacol. 2019;15:576-585."}, {"Citation": "AlShahrani A, AlShahrani I, Hosmani J, et al. Anticancer activity of Juniperus procera grown in southwestern region of Saudi Arabia on human oral squamous cell carcinoma cell lines. Pharmacogn Mag. 2020;16:499-509."}, {"Citation": "Alsubhi NS, Alharbi NS, Felimban AI. Optimized green synthesis and anticancer potential of silver nanoparticles using Juniperus procera extract against lung cancer cells. J Biomed Nanotechnol. 2022;18:2249-2263."}, {"Citation": "Alhayyani S, Akhdhar A, Asseri AH, et al. Potential anticancer activity of Juniperus procera and molecular docking models of active proteins in cancer cells. Molecules. 2023;28:2041.", "ArticleIdList": ["PMC10004709", "36903287"]}, {"Citation": "Martinchick J, Rahn M, Jolles C, Holden J. Human DNA topoisomerase II-alpha. Int J Oncol. 1997;10:1229-1234.", "ArticleIdList": ["21533509"]}, {"Citation": "Vanden Broeck A, Lotz C, Drillien R, Haas L, Bedez C, Lamour V. Structural basis for allosteric regulation of human topoisomerase II\u03b1. Nat Commun. 2021;12:2962.", "ArticleIdList": ["PMC8137924", "34016969"]}, {"Citation": "Skok Z, Zidar N, Kikelj D, Ila\u0161 J. Dual inhibitors of human DNA topoisomerase II and other cancer-related targets. J Med Chem. 2019;63:884-904.", "ArticleIdList": ["31592646"]}, {"Citation": "El-Senduny FF, Hegazi NM, Abd Elghani GE, Farag MA. Manuka honey, a unique mono-floral honey. A comprehensive review of its bioactives, metabolism, action mechanisms, and therapeutic merits. Food Biosci. 2021;42:101038."}, {"Citation": "Indrayanto G, Putra GS, Suhud F. Validation of in-vitro bioassay methods: application in herbal drug research. Profiles Drug Subst Excip Relat Methodol. 2021;46:273-307.", "ArticleIdList": ["33461699"]}, {"Citation": "Musa KH, Abdullah A, Kuswandi B, Hidayat MA. A novel high throughput method based on the DPPH dry reagent array for determination of antioxidant activity. Food Chem. 2013;141:4102-4106.", "ArticleIdList": ["23993591"]}, {"Citation": "Hoskins PJ, Swenerton KD. Oral etoposide is active against platinum-resistant epithelial ovarian cancer. J Clin Oncol. 1994;12:60-63.", "ArticleIdList": ["8270985"]}, {"Citation": "Muggia FM, Hainsworth JD, Jeffers S, et al. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol. 1997;15:987-993.", "ArticleIdList": ["9060537"]}, {"Citation": "Kongsawatvorakul C, Charakorn C, Chittithaworn S, Lertkhachonsuk AA. Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer. J Obstet Gynaecol. 2022;42:2331-2335.", "ArticleIdList": ["35470751"]}, {"Citation": "Foglietta F, Macr\u00ec M, Panzanelli P, et al. Ultrasound boosts doxorubicin efficacy against sensitive and resistant ovarian cancer cells. Eur J Pharm Biopharm. 2023;183:119-131.", "ArticleIdList": ["36632905"]}, {"Citation": "Sadowski J, Gasteiger J, Klebe G. Comparison of automatic three-dimensional model builders using 639 X-ray structures. J Chem Inf Comput Sci. 1994;34:1000-1008."}, {"Citation": "Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605-1612.", "ArticleIdList": ["15264254"]}, {"Citation": "Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998;19:1639-1662."}, {"Citation": "Zayene M, Algethami FK, Abdelhamid HN, et al. New synthetic quinaldine conjugates: assessment of their anti-cholinesterase, anti-tyrosinase and cytotoxic activities, and molecular docking analysis. Arab J Chem. 2022;15:104177."}, {"Citation": "Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64:4-17.", "ArticleIdList": ["11259830"]}, {"Citation": "Borges A, Jos\u00e9 H, Homem V, Sim\u00f5es M. Comparison of techniques and solvents on the antimicrobial and antioxidant potential of extracts from Acacia dealbata and Olea europaea. Antibiotics. 2020;9:48.", "ArticleIdList": ["PMC7168226", "32012935"]}, {"Citation": "Boik J. Natural Compounds in Cancer Therapy. 1st ed. Oregon Medical Press; 2001."}, {"Citation": "Top\u00e7u G, G\u00f6ren AC, Bilsel G, et al. Cytotoxic activity and essential oil composition of leaves and berries of Juniperus excelsa. Pharm Biol. 2005;43:125-128."}, {"Citation": "Esmaeili S, Hamzeloo-Moghadam M, Ghaffari S, Mosaddegh M. Cytotoxic activity screening of some medicinal plants from south of Iran. Res J Pharmacogn. 2014;1:19-25."}, {"Citation": "Singh M, Kaur M, Silakari O. Flavones: an important scaffold for medicinal chemistry. Eur J Med Chem. 2014;84:206-239.", "ArticleIdList": ["25019478"]}, {"Citation": "Kanadaswami C, Lee LT, Lee PPH, et al. The antitumor activities of flavonoids. In Vivo. 2005;19:895-909.", "ArticleIdList": ["16097445"]}, {"Citation": "Didier AJ, Stiene J, Fang L, Watkins D, Dworkin LD, Creeden JF. Antioxidant and anti-tumor effects of dietary vitamins A, C, and E. Antioxidants. 2023;12:632.", "ArticleIdList": ["0"]}, {"Citation": "\u0160amec D, Karalija E, Dahija S, Hassan ST. Biflavonoids: important contributions to the health benefits of Ginkgo (Ginkgo biloba L.). Plants. 2022;11:1381.", "ArticleIdList": ["PMC9143338", "35631806"]}, {"Citation": "Savaspun K, Boonchaisri S, Chaisuriya P, et al. Cytotoxicity and molecular docking to DNA topoisomerase II of chalcone flavokawain B isolated from Kaempferia elegans rhizomes. Sci Asia. 2023;49:421-427."}, {"Citation": "Lenin B, Ramasubramanyan S, Vetrivel U, Chitipothu S. Virtual screening and multilevel precision-based prioritisation of natural inhibitors targeting the ATPase domain of human DNA topoisomerase II alpha. J Biomol Struct Dyn. 2023;41:15177-15195.", "ArticleIdList": ["36898858"]}, {"Citation": "Talimarada D, Sharma A, Holla H. Identification of dual binding mode of Orthodiffenes towards human topoisomerase-I and \u03b1-tubulin: exploring the potential role in anti-cancer activity via in silico study. J Biomol Struct Dyn. 2023;41:2789-2803.", "ArticleIdList": ["35174766"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "3"}, {"Year": "2024", "Month": "4", "Day": "4"}, {"Year": "2024", "Month": "4", "Day": "29", "Hour": "6", "Minute": "45"}, {"Year": "2024", "Month": "4", "Day": "29", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "4", "Day": "29", "Hour": "4", "Minute": "10"}, {"Year": "2024", "Month": "4", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["38681095", "PMC11047251", "10.1177/11779322241248904", "10.1177_11779322241248904"]}}]}